Speaker(s): 

Moderator(s): 

Tristan Maiers, PharmD, BCOP, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• describe principles of cancer pain assessment, including pathophysiology, etiologies, and grading systems ​
• describe current pharmacologic cancer-related pain management principles
• describe the drug characteristics that impact the safety and efficacy of opioids​
• characterize the appropriate use of buprenorphine and methadone for cancer-related pain​

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Tristan Maiers, PharmD, BCOP, Rajiv Panikkar, MD, Michele Long, BSN, Jaime Weeder, NP and Christopher Kashi, PA-C have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant. 

Commerical Support for this Session

None.